View Item 

Show simple item record

Interaction Study between Digoxin and a Preparation of Hawthorn ( Crataegus oxyacantha )

dc.contributor.authorTankanow, Robertaen_US
dc.contributor.authorTamer, Helen R.en_US
dc.contributor.authorStreetman, Daniel S.en_US
dc.contributor.authorSmith, Scott G.en_US
dc.contributor.authorWelton, Janice L.en_US
dc.contributor.authorAnnesley, Thomasen_US
dc.contributor.authorAaronson, Keith D.en_US
dc.contributor.authorBleske, Barry E.en_US
dc.date.accessioned2013-04-08T20:50:12Z
dc.date.available2013-04-08T20:50:12Z
dc.date.issued2003-06en_US
dc.identifier.citationTankanow, Roberta; Tamer, Helen R.; Streetman, Daniel S.; Smith, Scott G.; Welton, Janice L.; Annesley, Thomas; Aaronson, Keith D.; Bleske, Barry E. (2003). "Interaction Study between Digoxin and a Preparation of Hawthorn ( Crataegus oxyacantha )." The Journal of Clinical Pharmacology 43(6). <http://hdl.handle.net/2027.42/97293>en_US
dc.identifier.issn0091-2700en_US
dc.identifier.issn1552-4604en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/97293
dc.publisherBlackwell Publishing Ltden_US
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherHeart Failureen_US
dc.subject.otherHawthornen_US
dc.subject.otherDigoxinen_US
dc.subject.otherPharmacokineticsen_US
dc.titleInteraction Study between Digoxin and a Preparation of Hawthorn ( Crataegus oxyacantha )en_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPediatricsen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumThe Department of Pathology, University of Michigan Health Systems, Ann Arbor, Michiganen_US
dc.contributor.affiliationumDepartment of Internal Medicine, University of Michigan Health Systems, Ann Arbor, Michigan.en_US
dc.contributor.affiliationumFrom the University of Michigan College of Pharmacy and University of Michigan Health Systems, Ann Arbor, Michiganen_US
dc.identifier.pmid12817526en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/97293/1/0091270003253417.pdf
dc.identifier.doi10.1177/0091270003253417en_US
dc.identifier.sourceThe Journal of Clinical Pharmacologyen_US
dc.identifier.citedreferenceObermeier MT, White RE, Yang CS: Effects of bioflavonoids on hepatic P450 activities. Xenobiotica 1995; 25: 575 – 584.en_US
dc.identifier.citedreferenceMunch G, Brixius K, Frank K, Erdmann E: WS 1442 (extract of Crataegus species) increases force of contraction in human failing myocardium by inhibition of the Na + /K + ‐ATPase. Circulation 1997; 96 ( Suppl. ): 4090.en_US
dc.identifier.citedreferenceSchussler M, Holzl J, Fricke W: Myocardial effects of flavonoids from Crataegus species. Arzneimittelforschung 1995; 45: 842 – 845.en_US
dc.identifier.citedreferenceBahorun T, Gressier B, Trotin F, Brunet C, Dine T, Luyckx M, et al: Oxygen species scavenging activity of phenolic extracts from hawthorn fresh plant organs and pharmaceutical preparations. Arzneimittelforschung 1996; 46: 1086 – 1089.en_US
dc.identifier.citedreferenceChen ZY, Zhang ZS, Kwan KY, Zhu M, Ho WKK, Huang Y: Endothelium‐dependent relaxation induced by hawthorn extract in rat mesenteric artery. Life Sci 1998; 63: 1983 – 1991.en_US
dc.identifier.citedreferenceKim SH, Kang KW, Kim KW, Kim ND: Procyanidins in Crataegus extract evoke endothelium‐dependent vasorelaxation in rat aorta. Life Sci 2000; 67: 121 – 131.en_US
dc.identifier.citedreferenceHolubarsch CJF, Colucci WS, Meinertz T, Gaus W, Tendera M: Survival and prognosis: investigations of Crataegus extract WS 1442 in congestive heart failure (SPICE): rationale, study design, and study protocol. Eur J Heart Failure 2000; 2: 431 – 437.en_US
dc.identifier.citedreferenceJohne A, Brockmoller J, Bauer S, Agathe M, Langheinrich M, Roots I: Pharmacokinetic interaction of digoxin with an herbal extract from St. John's wort (Hypericum perforatum). Clin Pharmacol Ther 1999; 66: 338 – 345.en_US
dc.identifier.citedreferenceCritchfield JW, Welsh CJ, Phang JM, Yeh GC: Modulation of adriamycin accumulation and efflux by flavonoids in HCT‐15 colon cells. Biochem Pharmacol 1994; 48: 1437 – 1445.en_US
dc.identifier.citedreferenceConseil G, Cortay HB, Dayan G, Jault JM, Barron D, Di Pietro A: Flavonoids: a class of modulators with bifunctional interactions at vicinal ATP‐ and steroid‐binding sites on mouse P‐glycoprotein. Proc Natl Acad Sci USA 1998; 95: 9831 – 9836.en_US
dc.identifier.citedreferenceShapiro AB, Ling V: Effect of quercetin on hoechst 33342 transport by purified and reconstituted P‐glycoprotein. Biochem Pharmacol 1997; 53: 587 – 596.en_US
dc.identifier.citedreferencePhang JM, Poore CM, Lopaczynska J, Yeh GC: Flavonol‐stimulated efflux of 7,12‐dimethylbenz(a)anthracene in multidrug‐resistant breast cancer cells. Cancer Res 1993; 53: 5977 – 5981.en_US
dc.identifier.citedreferenceHeart Failure Society of America: Guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction‐pharmacological approaches. J Cardiac Failure 1999; 5: 357 – 382.en_US
dc.identifier.citedreferenceNahrstedt A, Butterweck V: Biologically active and other chemical constituents of the herb of Hypericum perforatum L. Pharmacopsychiatry 1997; 30 ( Suppl. ): 129.en_US
dc.identifier.citedreferenceChang Q, Zhu M, Zuo Z, Chow M, Ho WK: High‐performance liquid chromatographic method for simultaneous determination of hawthorn active components in rat plasma. J Chromatogr B Biomed Sci Appl 2001; 760: 227 – 235.en_US
dc.identifier.citedreferenceZhang Z, Chang Q, Zhu M, Huang Y, Ho WK, Chen Z: Characterization of antioxidants present in hawthorn fruits. J Nutr Biochem 2001; 12: 144 – 152.en_US
dc.identifier.citedreferenceScambia G, Ranelletti FO, Panici PB, De Vincenzo R, Bonanno G, Ferrandina G, et al: Quercetin potentiates the effect of adriamycin in a multidrug‐resistant MCF‐7 human breast‐cancer cell line: P‐glycoprotein as a possible target. Cancer Chemother Pharmacol 1994; 34: 459 – 464.en_US
dc.identifier.citedreferenceErlund I, Kosonen T, Alfthan G, Maenpaa J, Perttunen K, Kenraali J, et al: Pharmacokinetics of quercetin aglycone and rutin in healthy volunteers. Eur J Clin Pharmacol 2000; 56: 545 – 553.en_US
dc.identifier.citedreferencePerloff MD, von Moltke LL, Stormer E, Shader RI, Greenblatt DJ: Saint John's wort: an in vitro analysis of P‐glycoprotein induction due to extended exposure. Br J Pharmacol 2001; 134: 1601 – 1608.en_US
dc.identifier.citedreferenceGreiner B, Eichelbaum M, Fritz P, Kreichgauer HP, von Richter O, Zundler J, et al: The role of intestinal P‐glycoprotein in the interaction of digoxin and rifampin. J Clin Invest 1999; 104: 147 – 153.en_US
dc.identifier.citedreferenceLacarelle B, Rahmani R, de Sousa G, Durand A, Placidi M, Cano JP: Metabolism of digoxin, digoxigenin digitoxosides and digoxigenin in human hepatocytes and liver microsomes. Fundam Clin Pharmacol 1991; 5: 567 – 582.en_US
dc.identifier.citedreferenceSchussler M, Holzl J, Rump AFE, Fricke U: Functional and antiischemic effects of monoacetyl‐vitexinrhamnoside in different in vitro models. Gen Pharmacol 1995; 26: 1565 – 1570.en_US
dc.identifier.citedreferenceRigelsky JM, Sweet BV: Hawthorn: pharmacology and therapeutic uses. Am J Health-Syst Pharm 2002; 59: 417 – 422.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
0091270003253417.pdf
Size:
83.58KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.